SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
E.on Se (ENAKF) trades at a trailing P/E of 34.6, forward P/E of 21.2. Trailing earnings yield is 2.89%, forward earnings yield 4.72%. PEG 0.34 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (40/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 21.2 (down from trailing 34.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.34 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 2.89% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 4.72% as earnings recover.
Overall SharesGrow Score: 58/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
40/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ENAKF
Valuation Multiples
P/E (TTM)34.6
Forward P/E21.2
PEG Ratio0.34
Forward PEG0.34
P/B Ratio0.00
P/S Ratio0.76
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.66
Forward EPS (Est.)$1.08
Book Value / Share$0.00
Revenue / Share$30.11
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.89%
Forward Earnings Yield4.72%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-4.13 |
$38.17B |
$-8.45B |
-22.1% |
| 2017 |
$1.84 |
$37.3B |
$3.93B |
10.5% |
| 2018 |
$1.49 |
$29.4B |
$3.22B |
11% |
| 2019 |
$0.60 |
$40.8B |
$1.55B |
3.8% |
| 2020 |
$0.39 |
$60.94B |
$1.02B |
1.7% |
| 2021 |
$1.80 |
$77.36B |
$4.69B |
6.1% |
| 2022 |
$0.70 |
$115.66B |
$1.83B |
1.6% |
| 2023 |
$0.18 |
$95.02B |
$517M |
0.5% |
| 2024 |
$1.73 |
$80.12B |
$4.53B |
5.7% |
| 2025 |
$0.66 |
$78.67B |
$1.73B |
2.2% |
